Rchr
J-GLOBAL ID：200901013681848625
Update date: Nov. 05, 2024
AIZAKI Yoshimi
アイザキ ヨシミ | AIZAKI Yoshimi
Affiliation and department：
Job title：
Research Assistant
Research theme for competitive and other funds (1)：
- 2009 - 2011 Benefical effect mechanism of ACE inhibitor without blood pressure reduction : New development of ACE intracellular signaling.
Papers (15)：
-
Omata Y, Tachibana H, Aizaki Y, Mimura T, Sato K. Essentiality of Nfatc1 short isoform in osteoclast differentiation and its self-regulation. Scientific Reports. 2023. 13. 1. 18979
-
Nakajima S, Tsuchiya H,Ota M, Ogawa M, Yamada S, Yoshida R, Maeda J, Shirai H, Kasai T, Hirose J, Ninagawa K, et al. Synovial Tissue Heterogeneity in Japanese Patients with Rheumatoid Arthritis Elucidated Using a Cell-Type Deconvolution Approach. Arthritis & Rheumatology. 2023
-
Yokota K, Sato K, Miyazaki T, Aizaki Y, Tanaka S, Sekikawa M, Kozu N, Kadono Y, Oda H, Mimura T. Characterization and Function of Tumor Necrosis Factor alpha and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis. Arthritis & Rheumatology. 2021. 73. 7. 1145-1154
-
Aizaki Y, Yazawa H, Sato K, Mimura T. Dual effects of interleukin 10 on natural killer cells and monocytes and the implications for adult-onset Still’s disease. Clinical & Experimental Rheumatology. 2021. 132. 5. 22-29
-
Asanuma YF, Aizaki Y, Noma H, Yokota K, Matsuda M, Kozu N, Takebayashi Y, Nakatani H, Hasunuma T, Kawai S, et al. Plasma pentraxin 3 is associated with progression of radiographic joint damage, but not carotid atherosclerosis, in female rheumatoid arthritis patients: 3-year prospective study. Modern Rheumatology. 2020. 30. 6. 959-966
ｍore...
Patents (1)：
-
ベーチェット病の判定を補助する方法、及びベーチェット病の活動性の評価を補助する方法
Books (2)：
-
「MR薬理学」
恒心社出版 2010
-
MR薬理学
恒心社出版 2010
Lectures and oral presentations (3)：
-
関節リウマチ滑膜線維芽細胞におけるMLL1阻害剤によるケモカインの発現抑制
(第8回JCRベーシックリサーチカンファレンス 2021)
-
Characterization and Function of Tumor Necrosis Factor α and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis.
(2021 ACR/ARP Annual Meeting 2021)
-
関節リウマチ滑膜線維芽細胞におけるWDR5阻害剤によるケモカインの発現抑制
(第49回日本臨床免疫学会総会 2021)
Association Membership(s) (1)：
Return to Previous Page
